H. Lundbeck AS (LUN):企業の財務・戦略的SWOT分析

◆英語タイトル:H. Lundbeck AS (LUN) - Financial and Strategic SWOT Analysis Review
◆商品コード:SWOT20MY1329
◆発行会社(調査会社):GlobalData
◆発行日:2020年4月
◆ページ数:64
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:デンマーク
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,125見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥26,250見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥39,375見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

H. Lundbeck AS (LUN) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

H. Lundbeck AS (Lundbeck), a subsidiary of The Lundbeck Foundation, carries out the research, development, manufacturing and marketing of pharmaceuticals for the treatment of the central nervous system (CNS) diseases including psychiatric and neurological disorders. The company’s products are indicated for the treatment of diseases such as Alzheimer’s disease, depression, Parkinson’s disease, schizophrenia, alcohol dependence, anxiety, bipolar I disorder, epilepsy and Huntington’s disease, among others. It operates production facilities in Denmark, France, Italy and China and research centers in China and Denmark. Lundbeck sells its products primarily to pharmaceutical distributors, pharmacies and hospitals in Europe, the US and other countries. Lundbeck is headquartered in Valby, Denmark.

H. Lundbeck AS Key Recent Developments

Mar 30,2020: Failed studies prompt Lundbeck to terminate foliglurax in Parkinson’s disease, Lu AG06466 in Tourette syndrome
Mar 11,2020: Aarhus University and the pharmaceutical industry join forces on open innovation – a pathway to new medicines
Mar 04,2020: Lundbeck receives grant from The Michael J. Fox Foundation for Parkinson’s disease research
Feb 24,2020: Lundbeck’s Vyepti secures US approval for migraine prevention
Jan 15,2020: NNIT and Lundbeck extend collaboration

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
H. Lundbeck AS – Key Facts
H. Lundbeck AS – Key Employees
H. Lundbeck AS – Key Employee Biographies
H. Lundbeck AS – Major Products and Services
H. Lundbeck AS – History
H. Lundbeck AS – Company Statement
H. Lundbeck AS – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
H. Lundbeck AS – Business Description
Product Category: Abilify Maintena
Overview
Performance
Product Category: Brintellix/Trintellix
Overview
Performance
Product Category: Cipralex/Lexapro
Overview
Performance
Product Category: Effects from Hedging
Performance
Product Category: Northera
Overview
Performance
Product Category: Onfi
Overview
Performance
Product Category: Other pharmaceuticals
Performance
Product Category: Other Revenue
Performance
Product Category: Rexulti
Overview
Performance
Product Category: Sabril
Overview
Performance
Geographical Segment: Europe
Target Markets
Performance
Geographical Segment: International Markets
Target Markets
Performance
Geographical Segment: North America
Performance
R&D Overview
H. Lundbeck AS – Corporate Strategy
H. Lundbeck AS – SWOT Analysis
SWOT Analysis – Overview
H. Lundbeck AS – Strengths
H. Lundbeck AS – Weaknesses
H. Lundbeck AS – Opportunities
H. Lundbeck AS – Threats
H. Lundbeck AS – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
H. Lundbeck AS, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
H. Lundbeck AS, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
H. Lundbeck AS, Recent Deals Summary
Section 5 – Company’s Recent Developments
Mar 04, 2020: Lundbeck receives grant from The Michael J. Fox Foundation for Parkinson’s disease research
Jan 15, 2020: NNIT and Lundbeck extend collaboration
Nov 05, 2019: H. Lundbeck: Double-digit growth for all strategic brands in 9M 2019 and FY 2019 guidance raised
Nov 05, 2019: Double-digit growth for all strategic brands in 9M 2019 and FY 2019 guidance raised
Sep 17, 2019: Lundbeck signs $1.95bn deal to buy Alder BioPharmaceuticals
Aug 14, 2019: Double-Lundbeck’s digit growth for all strategic brands and DKK 8.5 billion in revenue and DKK 2.3 billion in EBIT
Aug 14, 2019: Lundbeck appoints new EVP, People & Communication
May 30, 2019: Hyphens Pharma signs exclusive distribution agreement with Lundbeck for Vietnam
May 08, 2019: H. Lundbeck: Double-digit growth for all strategic brands and DKK 4,234 million in revenue and DKK 1,200 million in EBIT
May 07, 2019: Lundbeck to purchase Abide Therapeutics in $400m deal
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
H. Lundbeck AS, Key Facts
H. Lundbeck AS, Key Employees
H. Lundbeck AS, Key Employee Biographies
H. Lundbeck AS, Major Products and Services
H. Lundbeck AS, History
H. Lundbeck AS, Subsidiaries
H. Lundbeck AS, Key Competitors
H. Lundbeck AS, Ratios based on current share price
H. Lundbeck AS, Annual Ratios
H. Lundbeck AS, Annual Ratios (Cont...1)
H. Lundbeck AS, Annual Ratios (Cont...2)
H. Lundbeck AS, Interim Ratios
H. Lundbeck AS, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
H. Lundbeck AS, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
H. Lundbeck AS, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures
H. Lundbeck AS, Performance Chart (2015 - 2019)
H. Lundbeck AS, Ratio Charts
H. Lundbeck AS, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
H. Lundbeck AS, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

★海外企業調査レポート[H. Lundbeck AS (LUN):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Fukoku Mutual Life Insurance Company:企業の戦略・SWOT・財務情報
    Fukoku Mutual Life Insurance Company - Strategy, SWOT and Corporate Finance Report Summary Fukoku Mutual Life Insurance Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Baxter International Inc.:企業の戦略・SWOT・財務情報
    Baxter International Inc. - Strategy, SWOT and Corporate Finance Report Summary Baxter International Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Myriad Genetics Inc (MYGN):製薬・医療:M&Aディール及び事業提携情報
    Summary Myriad Genetics Inc (Myriad) is a specialty molecular diagnostic company, which discovers and commercializes molecular diagnostic tests, personalized medicine and services for major diseases. The company’s product portfolio includes molecular diagnostic testing products that analyze genes, t …
  • Stem Inc:電力:M&Aディール及び事業提携情報
    Summary Stem, Inc. (Stem) is a provider of energy storage solutions and software to businesses for managing energy costs. It leverages big data, predictive analytics, cloud computing, and advanced energy storage to reduce peak electrical usage, lower electric bills, and eliminate the need for new ge …
  • AutoZone, Inc.:企業の戦略・SWOT・財務情報
    AutoZone, Inc. - Strategy, SWOT and Corporate Finance Report Summary AutoZone, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Drexel University:製薬・医療:M&Aディール及び事業提携情報
    Summary Drexel University (Drexel) is a research university which provides educational degrees and research programs. The university offers courses for undergraduate courses, graduate and professional courses, adult education programs, colleges and schools, libraries and online training services. It …
  • Ellex Medical Lasers Limited (ELX):企業の財務・戦略的SWOT分析
    Ellex Medical Lasers Limited (ELX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Insperity, Inc. (NSP):企業の財務・戦略的SWOT分析
    Insperity, Inc. (NSP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Telefonica, S.A.:戦略・SWOT・企業財務分析
    Telefonica, S.A. - Strategy, SWOT and Corporate Finance Report Summary Telefonica, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Shin-Etsu Chemical Co., Ltd.:企業の戦略・SWOT・財務情報
    Shin-Etsu Chemical Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Shin-Etsu Chemical Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Halt Medical Inc-製薬・医療分野:企業M&A・提携分析
    Summary Halt Medical Inc (Halt Medical) is a healthcare service center that develops, manufactures and commercializes medical treatment for women with symptomatic uterine fibroids. The center offers Acessa System, a minimally invasive laparoscopic outpatient procedure to treat uterine fibroids. It o …
  • Bio-Rad Laboratories Inc (BIO):医療機器:M&Aディール及び事業提携情報
    Summary Bio-Rad Laboratories Inc (Bio-Rad) develops, manufactures and markets a range of products and systems for the life science research, healthcare, analytical chemistry and other markets. The company’s major products include reagents, apparatus, laboratory instruments, test systems, informatics …
  • CullenFrost Bankers Inc (CFR):企業の財務・戦略的SWOT分析
    CullenFrost Bankers Inc (CFR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Atria Plc:戦略・SWOT・企業財務分析
    Atria Plc - Strategy, SWOT and Corporate Finance Report Summary Atria Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions …
  • BT Group plc:企業の戦略・SWOT・財務情報
    BT Group plc - Strategy, SWOT and Corporate Finance Report Summary BT Group plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • AECOM (ACM):企業の財務・戦略的SWOT分析
    AECOM (ACM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the poten …
  • SATCO Products Inc:企業の戦略的SWOT分析
    SATCO Products Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • CCP Technologies Ltd (CT1):医療機器:M&Aディール及び事業提携情報
    Summary CCP Technologies Ltd (CCP), formerly Agenix Ltd, is a technology company that offers business-to-business hardware and software solutions. The company develops Internet of Things’ solutions for management of computers, smart phones, sensors and diverse equipment. It offers business hardware …
  • Apollo Education Group, Inc.:企業の戦略・SWOT・財務分析
    Apollo Education Group, Inc. - Strategy, SWOT and Corporate Finance Report Summary Apollo Education Group, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Intrum Justitia AB:企業のM&A・事業提携・投資動向
    Intrum Justitia AB - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Intrum Justitia AB Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆